Deletion of CCR1 Attenuates Pathophysiologic Responses during Respiratory Syncytial Virus Infection
暂无分享,去创建一个
[1] C. Duckett,et al. Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.
[2] M. Schaller,et al. Respiratory syncytial virus‐induced exaggeration of allergic airway disease is dependent upon CCR1‐associated immune responses , 2005, European journal of immunology.
[3] B. Graham,et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. , 2004, American journal of respiratory and critical care medicine.
[4] N. Lukacs,et al. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.
[5] E. Gelfand,et al. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. , 2003, The Journal of allergy and clinical immunology.
[6] P. Tak,et al. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[7] K. Harrod,et al. Clara Cell Secretory Protein Modulates Lung Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection1 , 2003, The Journal of Immunology.
[8] N. Lukacs,et al. Respiratory syncytial virus‐induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation , 2003, European journal of immunology.
[9] A. Naya,et al. CCR1 chemokine receptor antagonist. , 2003, Current pharmaceutical design.
[10] A. Gruber,et al. CXCR2 Regulates Respiratory Syncytial Virus-Induced Airway Hyperreactivity and Mucus Overproduction1 , 2003, The Journal of Immunology.
[11] R. Welliver. Respiratory syncytial virus and other respiratory viruses , 2003, The Pediatric infectious disease journal.
[12] F. Martinez. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma , 2003, The Pediatric infectious disease journal.
[13] R. Lemanske. The Childhood Origins of Asthma (COAST) study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[14] S. Kunkel,et al. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease , 2002, European journal of immunology.
[15] B. Graham,et al. The Role of IFN in Respiratory Syncytial Virus Pathogenesis , 2002, The Journal of Immunology.
[16] M. Koss,et al. Bronchiolitis: update 2001. , 2002, Current opinion in pulmonary medicine.
[17] E. Raz,et al. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. , 2001, The Journal of allergy and clinical immunology.
[18] Prince Am,et al. Prevention of respiratory syncytial virus infection in high risk infants. , 2001, The Journal of the Arkansas Medical Society.
[19] R. Garofalo,et al. Macrophage Inflammatory Protein-1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus Bronchiolitis , 2001 .
[20] M. Kaplan,et al. Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. , 2001, The American journal of pathology.
[21] L. O’Neill. Gob genes, mucus and asthma. , 2001, Trends in immunology.
[22] W. Heath. Motility is more important that stealth , 2001 .
[23] Yukio Fujisawa,et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Garofalo,et al. Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial Virus-Infected Mice: Role of MIP-1α in Lung Pathology , 2001, Journal of Virology.
[25] P. Openshaw,et al. IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions1 , 2000, The Journal of Immunology.
[26] H. Rosenberg,et al. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. , 2000, Cellular immunology.
[27] H. Popper. Bronchiolitis, an update , 2000, Virchows Archiv.
[28] T. Noah,et al. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. , 2000, Clinical immunology.
[29] B. Graham,et al. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. , 2000, Immunopharmacology.
[30] R. Lockey,et al. Recurrent Respiratory Syncytial Virus Infections in Allergen-Sensitized Mice Lead to Persistent Airway Inflammation and Hyperresponsiveness1 , 2000, The Journal of Immunology.
[31] R. Horuk,et al. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. , 2000, European journal of pharmacology.
[32] J. Cyster,et al. Leukocyte migration: Scent of the T zone , 2000, Current Biology.
[33] R. Lockey,et al. Intranasal IFN-γ gene transfer protects BALB/c mice against respiratory syncytial virus infection , 1999 .
[34] T. Braciale,et al. Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent , 1999, Journal of Virology.
[35] H. Rosenberg,et al. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. , 1999, American journal of respiratory and critical care medicine.
[36] E. Gelfand,et al. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. , 1999, Journal of immunology.
[37] H. Rosenberg,et al. Macrophage inflammatory protein‐1α and RANTES are present in nasal secretions during ongoing upper respiratory tract infection , 1999 .
[38] R. Strieter,et al. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. , 1998, Journal of immunology.
[39] J. Westwick,et al. Chemokines: understanding their role in T-lymphocyte biology. , 1998, The Biochemical journal.
[40] J. Friedland,et al. Respiratory Syncytial Virus-Induced RANTES Production from Human Bronchial Epithelial Cells Is Dependent on Nuclear Factor-κB Nuclear Binding and Is Inhibited by Adenovirus-Mediated Expression of Inhibitor of κBα , 1998, The Journal of Immunology.
[41] R. Garofalo,et al. Cell-Specific Expression of RANTES, MCP-1, and MIP-1α by Lower Airway Epithelial Cells and Eosinophils Infected with Respiratory Syncytial Virus , 1998, Journal of Virology.
[42] A. Saluja,et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. , 1997, The Journal of clinical investigation.
[43] B. Graham,et al. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. , 1997, The Journal of clinical investigation.
[44] T. Noah,et al. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. , 1997, The American journal of physiology.
[45] R. Garofalo,et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. , 1997, The Journal of infectious diseases.
[46] B. Graham,et al. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. , 1995, The Journal of infectious diseases.
[47] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.